Trial Profile
Clinical Observation of the Efficacy and Safety of Risperidone Long-Acting Injection (Risperdal Consta) in the Treatment of Schizophrenia in China
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Antipsychotics; Benzodiazepines; Serotonin uptake inhibitors
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Xian-Janssen
- 13 Jul 2013 New trial record